George Poste

George H.
Poste is Chief Executive Officer at Health Technology Networks, Inc. since 2000.
He is an Independent Director at Exelixis, Inc. since 2004.
He serves as Director at Caris Holdings Ltd. and Medisix Therapeutics, Inc. He is a Member of the Council on Foreign Relations, Inc. He is Chief Scientist at the Complex Adaptive Systems Initiative since 2009.
He is a Member of The Hoover Institution.
Formerly, Dr. Poste was Non-Executive Chairman at Orchid Cellmark, Inc. from 2000 to 2009, diaDexus, Inc. from 1997 to 2004, and SGX Pharmaceuticals, Inc. from 2000 to 2004.
He was Vice Chairman at Caris Life Sciences, Inc. from 2008 to 2026.
He was Director at Caremark Rx, Inc., AdvancePCS from 2002 to 2005, Illumina, Inc. from 2000 to 2003, Structural Genomix, Inc. from 2000 to 2003, and held director roles at Monsanto Co. from 2012 to 2018, Arizona State University from 2003 to 2009, Biodesign Institute from 2003 to 2009, INanoBio, Inc., Calviri, Inc., and Caris Ltd. He was Chief Science & Technology Officer at GSK Plc and GlaxoSmithKline LLC from 1992 to 1999.
He was Member-Defense Science Board at the US Department of Defense from 2001 to 2010.
He was a Member of the Bipartisan Commission On Biodefense from 2000 to 2009.
Education includes doctorates conferred by the University of Bristol in 1969 and 1987.